Menu Back to 5th-DIA-Cardiac-Safety-Workshop-in-Japan

Program Committee

  • Hiroyuki  Fukase, DrMed, MD, PhD
    Hiroyuki Fukase, DrMed, MD, PhD
    Medipolis Medical Research Institute, CPC Clinical Trial Hospital, Japan
  • Boaz  Mendzelevski, MD
    Boaz Mendzelevski, MD Vice President of Cardiology
    BioClinica, Inc., United Kingdom
  • Kentaro  Ando, PhD
    Kentaro Ando, PhD Dept of Pharmacology
    Toho University School of Medicine, Japan
  • Zhe  Jin, MD, PhD
    Zhe Jin, MD, PhD Safety Physician, Manager, Japan Safety & Surveillance Div, R&D
    Janssen Pharmaceutical K.K., Japan
  • Yuji  Kumagai, MD, PhD
    Yuji Kumagai, MD, PhD Director, Clinical Trial Center
    Kitasato University East Hospital, Japan
  • Koki  Nakamura, MD, PhD
    Koki Nakamura, MD, PhD Vice President, Global Medical Affairs-Japan, Takeda Development Center Japan
    Takeda Pharmaceutical Company Limited, Japan
  • Kaori  Shinagawa, MD, PhD
    Kaori Shinagawa, MD, PhD Senior Scientist for Clinical Medicine, Office of New Drug ll
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Atsushi  Sugiyama, MD, PhD
    Atsushi Sugiyama, MD, PhD Professor and Chairman, Dept of Pharmacology, Faculty of Medicine
    Toho University, Japan
Load More